Meds & supplements › Zafirlukast
Medicine · Leukotriene Receptor Antagonist
Zafirlukast is indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older.
Selected manufacturer label information, organised into consistent sections by Sofidex. Read the full label at DailyMed ↗
Zafirlukast tablets are a prescription medicine used to help prevent asthma attacks and for the long-term treatment of asthma symptoms in adults and children 5 years and older.
It is not known if zafirlukast tablets are safe and effective when used in children under 5 years old. The effect of zafirlukast tablets on growth in children has not been determined.
Do not take zafirlukast tablets if you need relief right away for a sudden asthma attack. If you get an asthma attack, you should follow the instructions your healthcare provider gave you for treating asthma attacks.
Zafirlukast tablets may cause serious side effects, including:
The most common side effects of zafirlukast tablets in people 12 years and older include:
The most common side effects of zafirlukast tablets in children 5 to 11 years include:
Tell your healthcare provider if you have any side effect that bothers you or that does not go away.
These are not all of the possible side effects of zafirlukast tablets. For more information, ask your healthcare provider or pharmacist.
Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
You may also report side effects to Aurobindo Pharma USA, Inc. at 1-866-850-2876.
Do not take zafirlukast tablets if you;
Before you take zafirlukast tablets, tell your healthcare provider if you:
Tell your healthcare provider about all the medicines you take, including prescription and non-prescription medicines, vitamins, and herbal supplements.
Zafirlukast tablets may affect the way other medicines work, and other medicines may affect how zafirlukast tablets works.
Especially tell your healthcare provider if you take:
Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine.
General information about the safe and effective use of zafirlukast tablets.
Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use zafirlukast tablets for a condition for which it was not prescribed. Do not give zafirlukast tablets to other people, even if they have the same symptoms that you have. They may harm them.
This Patient Information leaflet summarizes the most important information about zafirlukast tablets. If you would like more information, talk with your healthcare provider. You can ask your pharmacist or healthcare provider for information about zafirlukast tablets that is written for healthcare professionals.
For more information, call Aurobindo Pharma USA, Inc. at 1-866-850-2876.
The brands listed are trademarks of their respective owners and are not trademarks of Aurobindo Pharma Limited.
Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520 Manufactured by: Aurobindo Pharma Limited Hyderabad-500 032, India Issued: June 2023
sofidex [Internet]. Daloreum; c2026. Zafirlukast; [reviewed 2026 Aug 3; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/zafirlukast
sofidex. (2026, August 3). Zafirlukast. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/zafirlukast
Zafirlukast. sofidex. Reviewed August 3, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/zafirlukast
The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.